Arthritis Research & Therapy

official impact factor 4.36
Search for
Advanced search
Arthritis Research & Therapy
Tools
Share this article

This article is part of the supplement: Targeting B cells in autoimmune diseases

Highly Access

B cell depletion in autoimmune disease

Claire Gorman, Maria Leandro and David Isenberg*

Arthritis Res Ther 2003, 5(Suppl 4):S17-S21 doi:10.1186/ar1007

Accesses  

  • Last 30 days: 57 accesses
  • Last 365 days: 698 accesses
  • All time: 9663 accesses

Cited by

BioMed Central: 2 citations

Research article   Open Access Highly Accessed

Clinical and immunological effects of Rituximab in patients with lupus nephritis refractory to conventional therapy: a pilot study

Mónica Vigna-Perez, Berenice Hernández-Castro, Octavio Paredes-Saharopulos, Diana Portales-Pérez, Lourdes Baranda, Carlos Abud-Mendoza, Roberto González-Amaro Arthritis Research & Therapy 2006, 8:R83 (5 May 2006)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Research article   Open Access

Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody

Anne-Sophie Rouzière, Christian Kneitz, Arumugam Palanichamy, Thomas Dörner, Hans-Peter Tony Arthritis Research & Therapy 2005, 7:R714-R724 (1 April 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

PubMed Central: View citations